Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer

Yanjie Xu, Ye Hwan Kim, Pildu Jeong, Xuan Mei Piao, Young Joon Byun, Sung Pil Seo, Ho Won Kang, Won Tae Kim, Jong Young Lee, Dong Hee Ryu, Jae Woon Choi, Isaac Y. Kim, Sung Kwon Moon, Yung Hyun Choi, Seok Joong Yun, Wun Jae Kim

Research output: Contribution to journalArticle

Abstract

Background: Disease monitoring in non–muscle-invasive bladder cancer (NMIBC) patients is crucial for early identification of disease recurrence and progression. High IQGAP3/BMP4 and IQGAP3/FAM107A ratios in urinary cell-free DNA (ucfDNA) are a diagnostic biomarker for bladder cancer. We aimed to investigate whether the levels of these biomarkers in ucfDNA can be used to monitor disease recurrence or progression in patients with NMIBC. Patients and Methods: A total of 103 patients with NMIBC (pTa-pT1) were enrolled. The IQGAP3/BMP4 and IQGAP3/FAM107A ratios in ucfDNA were measured by real-time PCR, and the results were compared with clinical outcome by Kaplan-Meier curves and Cox regression analyses. Results: Overall, 55 patients (53.4%) experienced recurrence and 29 (28.2%) experienced disease progression during a median follow-up of 42.7 months (range, 6.1-172.2 months). Kaplan-Meier analysis revealed that NMIBC patients with a high IQGAP3/BMP4 ratio had worse recurrence-free survival and progression-free survival (PFS) (P =.001 and <.001, respectively), and those with a high IQGAP3/FAM107A ratio had worse PFS (P =.006). Multivariate Cox regression analysis revealed that the IQGAP3/BMP4 ratio was independently associated with recurrence-free survival (hazard ratio, 2.462; P =.003) and PFS (hazard ratio = 3.871; P =.004), whereas the IQGAP3/FAM107A ratio was not an independent factor for PFS (P =.079). Conclusion: The IQGAP3/BMP4 ratio in ucfDNA might be a valuable novel biomarker for predicting disease recurrence and progression in patients with NMIBC.

Original languageEnglish (US)
Pages (from-to)e704-e711
JournalClinical Genitourinary Cancer
Volume17
Issue number3
DOIs
StatePublished - Jun 2019

Fingerprint

Urinary Bladder Neoplasms
DNA
Recurrence
Disease-Free Survival
Disease Progression
Biomarkers
Regression Analysis
Kaplan-Meier Estimate
Real-Time Polymerase Chain Reaction
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Keywords

  • Biomarker
  • NMIBC
  • Prognosis
  • Urinary cell-free DNA

Cite this

Xu, Yanjie ; Kim, Ye Hwan ; Jeong, Pildu ; Piao, Xuan Mei ; Byun, Young Joon ; Seo, Sung Pil ; Kang, Ho Won ; Kim, Won Tae ; Lee, Jong Young ; Ryu, Dong Hee ; Choi, Jae Woon ; Kim, Isaac Y. ; Moon, Sung Kwon ; Choi, Yung Hyun ; Yun, Seok Joong ; Kim, Wun Jae. / Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer. In: Clinical Genitourinary Cancer. 2019 ; Vol. 17, No. 3. pp. e704-e711.
@article{f0563747606c48fbb9c9dfabec824152,
title = "Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer",
abstract = "Background: Disease monitoring in non–muscle-invasive bladder cancer (NMIBC) patients is crucial for early identification of disease recurrence and progression. High IQGAP3/BMP4 and IQGAP3/FAM107A ratios in urinary cell-free DNA (ucfDNA) are a diagnostic biomarker for bladder cancer. We aimed to investigate whether the levels of these biomarkers in ucfDNA can be used to monitor disease recurrence or progression in patients with NMIBC. Patients and Methods: A total of 103 patients with NMIBC (pTa-pT1) were enrolled. The IQGAP3/BMP4 and IQGAP3/FAM107A ratios in ucfDNA were measured by real-time PCR, and the results were compared with clinical outcome by Kaplan-Meier curves and Cox regression analyses. Results: Overall, 55 patients (53.4{\%}) experienced recurrence and 29 (28.2{\%}) experienced disease progression during a median follow-up of 42.7 months (range, 6.1-172.2 months). Kaplan-Meier analysis revealed that NMIBC patients with a high IQGAP3/BMP4 ratio had worse recurrence-free survival and progression-free survival (PFS) (P =.001 and <.001, respectively), and those with a high IQGAP3/FAM107A ratio had worse PFS (P =.006). Multivariate Cox regression analysis revealed that the IQGAP3/BMP4 ratio was independently associated with recurrence-free survival (hazard ratio, 2.462; P =.003) and PFS (hazard ratio = 3.871; P =.004), whereas the IQGAP3/FAM107A ratio was not an independent factor for PFS (P =.079). Conclusion: The IQGAP3/BMP4 ratio in ucfDNA might be a valuable novel biomarker for predicting disease recurrence and progression in patients with NMIBC.",
keywords = "Biomarker, NMIBC, Prognosis, Urinary cell-free DNA",
author = "Yanjie Xu and Kim, {Ye Hwan} and Pildu Jeong and Piao, {Xuan Mei} and Byun, {Young Joon} and Seo, {Sung Pil} and Kang, {Ho Won} and Kim, {Won Tae} and Lee, {Jong Young} and Ryu, {Dong Hee} and Choi, {Jae Woon} and Kim, {Isaac Y.} and Moon, {Sung Kwon} and Choi, {Yung Hyun} and Yun, {Seok Joong} and Kim, {Wun Jae}",
year = "2019",
month = "6",
doi = "10.1016/j.clgc.2019.04.001",
language = "English (US)",
volume = "17",
pages = "e704--e711",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",

}

Xu, Y, Kim, YH, Jeong, P, Piao, XM, Byun, YJ, Seo, SP, Kang, HW, Kim, WT, Lee, JY, Ryu, DH, Choi, JW, Kim, IY, Moon, SK, Choi, YH, Yun, SJ & Kim, WJ 2019, 'Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer', Clinical Genitourinary Cancer, vol. 17, no. 3, pp. e704-e711. https://doi.org/10.1016/j.clgc.2019.04.001

Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer. / Xu, Yanjie; Kim, Ye Hwan; Jeong, Pildu; Piao, Xuan Mei; Byun, Young Joon; Seo, Sung Pil; Kang, Ho Won; Kim, Won Tae; Lee, Jong Young; Ryu, Dong Hee; Choi, Jae Woon; Kim, Isaac Y.; Moon, Sung Kwon; Choi, Yung Hyun; Yun, Seok Joong; Kim, Wun Jae.

In: Clinical Genitourinary Cancer, Vol. 17, No. 3, 06.2019, p. e704-e711.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non–Muscle-Invasive Bladder Cancer

AU - Xu, Yanjie

AU - Kim, Ye Hwan

AU - Jeong, Pildu

AU - Piao, Xuan Mei

AU - Byun, Young Joon

AU - Seo, Sung Pil

AU - Kang, Ho Won

AU - Kim, Won Tae

AU - Lee, Jong Young

AU - Ryu, Dong Hee

AU - Choi, Jae Woon

AU - Kim, Isaac Y.

AU - Moon, Sung Kwon

AU - Choi, Yung Hyun

AU - Yun, Seok Joong

AU - Kim, Wun Jae

PY - 2019/6

Y1 - 2019/6

N2 - Background: Disease monitoring in non–muscle-invasive bladder cancer (NMIBC) patients is crucial for early identification of disease recurrence and progression. High IQGAP3/BMP4 and IQGAP3/FAM107A ratios in urinary cell-free DNA (ucfDNA) are a diagnostic biomarker for bladder cancer. We aimed to investigate whether the levels of these biomarkers in ucfDNA can be used to monitor disease recurrence or progression in patients with NMIBC. Patients and Methods: A total of 103 patients with NMIBC (pTa-pT1) were enrolled. The IQGAP3/BMP4 and IQGAP3/FAM107A ratios in ucfDNA were measured by real-time PCR, and the results were compared with clinical outcome by Kaplan-Meier curves and Cox regression analyses. Results: Overall, 55 patients (53.4%) experienced recurrence and 29 (28.2%) experienced disease progression during a median follow-up of 42.7 months (range, 6.1-172.2 months). Kaplan-Meier analysis revealed that NMIBC patients with a high IQGAP3/BMP4 ratio had worse recurrence-free survival and progression-free survival (PFS) (P =.001 and <.001, respectively), and those with a high IQGAP3/FAM107A ratio had worse PFS (P =.006). Multivariate Cox regression analysis revealed that the IQGAP3/BMP4 ratio was independently associated with recurrence-free survival (hazard ratio, 2.462; P =.003) and PFS (hazard ratio = 3.871; P =.004), whereas the IQGAP3/FAM107A ratio was not an independent factor for PFS (P =.079). Conclusion: The IQGAP3/BMP4 ratio in ucfDNA might be a valuable novel biomarker for predicting disease recurrence and progression in patients with NMIBC.

AB - Background: Disease monitoring in non–muscle-invasive bladder cancer (NMIBC) patients is crucial for early identification of disease recurrence and progression. High IQGAP3/BMP4 and IQGAP3/FAM107A ratios in urinary cell-free DNA (ucfDNA) are a diagnostic biomarker for bladder cancer. We aimed to investigate whether the levels of these biomarkers in ucfDNA can be used to monitor disease recurrence or progression in patients with NMIBC. Patients and Methods: A total of 103 patients with NMIBC (pTa-pT1) were enrolled. The IQGAP3/BMP4 and IQGAP3/FAM107A ratios in ucfDNA were measured by real-time PCR, and the results were compared with clinical outcome by Kaplan-Meier curves and Cox regression analyses. Results: Overall, 55 patients (53.4%) experienced recurrence and 29 (28.2%) experienced disease progression during a median follow-up of 42.7 months (range, 6.1-172.2 months). Kaplan-Meier analysis revealed that NMIBC patients with a high IQGAP3/BMP4 ratio had worse recurrence-free survival and progression-free survival (PFS) (P =.001 and <.001, respectively), and those with a high IQGAP3/FAM107A ratio had worse PFS (P =.006). Multivariate Cox regression analysis revealed that the IQGAP3/BMP4 ratio was independently associated with recurrence-free survival (hazard ratio, 2.462; P =.003) and PFS (hazard ratio = 3.871; P =.004), whereas the IQGAP3/FAM107A ratio was not an independent factor for PFS (P =.079). Conclusion: The IQGAP3/BMP4 ratio in ucfDNA might be a valuable novel biomarker for predicting disease recurrence and progression in patients with NMIBC.

KW - Biomarker

KW - NMIBC

KW - Prognosis

KW - Urinary cell-free DNA

UR - http://www.scopus.com/inward/record.url?scp=85065448798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065448798&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2019.04.001

DO - 10.1016/j.clgc.2019.04.001

M3 - Article

AN - SCOPUS:85065448798

VL - 17

SP - e704-e711

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -